HeartWare Touts Promising Pipeline During Third-Quarter Call

HeartWare International plans to present data from the Endurance destination therapy trial of its ventricular assist device in early 2015 and could file a PMA sometime before that, CEO Doug Godshall said on a Thursday third-quarter earnings call.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00